Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct-Dec;29(4):417-423.
doi: 10.20524/aog.2016.0070. Epub 2016 Jul 14.

Barrett's esophagus: lessons from recent clinical trials

Affiliations
Review

Barrett's esophagus: lessons from recent clinical trials

Daniela Golger et al. Ann Gastroenterol. 2016 Oct-Dec.

Abstract

Data from recent studies cast doubt on former recommendations on diagnosis and management of Barrett's esophagus. Based on latest research findings several Gastroenterological Associations actualized their guidelines and international experts compiled consensus statements as practical help for clinicians. In this review we discuss recent trials and their impact on clinical practice, current recommendations and persisting controversies in Barrett's esophagus.

Keywords: Barrett’s esophagus; endoscopic eradication; endoscopic mucosal resection; endoscopic submucosal dissection; esophageal adenocarcinoma.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Management of Barrett’s esophagus HGD, high-grade dysplasia; LGD, low-grade dysplasia; RFA, radiofrequency ablation.
Figure 2
Figure 2
(A) Early esophageal adenocarcinoma (narrow band imaging); (B) after endoscopic submucosal dissection

Similar articles

Cited by

References

    1. Hur C, Miller M, Kong CY, et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer. 2013;119:1149–1158. - PMC - PubMed
    1. Verbeek RE, Leenders M, Ten Kate FJ, et al. Surveillance of Barrett’s esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study. Am J Gastroenterol. 2014;109:1215–1222. - PubMed
    1. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365:1375–1383. - PubMed
    1. Desai TK, Krishnan K, Samala N, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61:970–976. - PubMed
    1. Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. JNCI J Natl Cancer Inst. 2011;103:1049–1057. - PMC - PubMed

LinkOut - more resources